Lupin Infringes Exeltis Contraceptive Patents, Judge Finds
By Leslie A. Pappas · September 5, 2024, 7:53 PM EDT
Mumbai-based generic-pharmaceuticals company Lupin Pharmaceuticals Inc. has infringed five patents of the estrogen-free contraceptive Slynd, a Delaware federal judge said Wednesday, finding in favor of Spanish pharmaceutical company Insud Pharma and...
To view the full article, register now.